Vertical transmission of hepatitis C virus: Current knowledge and perspectives
- PMID: 25276280
- PMCID: PMC4179143
- DOI: 10.4254/wjh.v6.i9.643
Vertical transmission of hepatitis C virus: Current knowledge and perspectives
Abstract
Hepatitis C virus (HCV) infection is a major global health issue. Infection by the HCV can cause acute and chronic liver diseases and may lead to cirrhosis, hepatocellular carcinoma or liver failure. The World Health Organization estimates that approximately 3% of the world population have been infected with HCV and the worldwide prevalence is between 1% and 8% in pregnant women and between 0.05% and 5% in children. Following the introduction of blood product screening, vertical transmission becomes the leading cause of childhood HCV infection. The prevalence of pediatric HCV infection varies from 0.05% to 0.36% in developed countries and between 1.8% and 5% in the developing world. All children born to women with anti-HCV antibodies should be checked for HCV infection. Though universal screening is controversial, selective antenatal HCV screening on high-risk populations is highly recommended and should be tested probably. Multiple risk factors were shown to increase the possibility of HCV vertical transmission, including coinfections with human immunodeficiency virus, intravenous drug use and elevated maternal HCV viral load, while breastfeeding and HCV genotypes have been studied to have little impact. At present, no clinical intervention has been clearly studied and proved to reduce the HCV vertical transmission risk. Cesarean section should not be recommended as a procedure to prevent vertical transmission, however, breastfeeding is generally not forbidden. The high prevalence of global HCV infection necessitates renewed efforts in primary prevention, including vaccine development, as well as new approaches to reduce the burden of chronic liver disease. Future researches should focus on the interruption of vertical transmission, developments of HCV vaccine and direct-acting antivirals in infancy and early childhood.
Keywords: Chronic liver disease; Hepatitis C virus; Perinatal infection; Vertical transmission.
Similar articles
-
Vertical hepatitis C virus transmission: Main questions and answers.World J Hepatol. 2014 Aug 27;6(8):538-48. doi: 10.4254/wjh.v6.i8.538. World J Hepatol. 2014. PMID: 25232447 Free PMC article. Review.
-
Burden of pediatric hepatitis C.World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880. World J Gastroenterol. 2013. PMID: 24307782 Free PMC article. Review.
-
Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment?J Viral Hepat. 2011 Apr;18(4):229-36. doi: 10.1111/j.1365-2893.2010.01413.x. Epub 2011 Jan 7. J Viral Hepat. 2011. PMID: 21392169 Review.
-
Perinatal transmission of hepatitis C virus infection.J Med Virol. 2009 May;81(5):836-43. doi: 10.1002/jmv.21437. J Med Virol. 2009. PMID: 19319981 Review.
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714 Review.
Cited by
-
Towards elimination of chronic viral hepatitis in French Polynesia: results from a national population-based survey.Lancet Reg Health West Pac. 2024 Mar 2;45:101035. doi: 10.1016/j.lanwpc.2024.101035. eCollection 2024 Apr. Lancet Reg Health West Pac. 2024. PMID: 38445260 Free PMC article.
-
HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation.Drug Metab Dispos. 2024 May 16;52(6):516-525. doi: 10.1124/dmd.123.001434. Drug Metab Dispos. 2024. PMID: 38267095 Free PMC article.
-
Core fucosylation and its roles in gastrointestinal glycoimmunology.World J Gastrointest Oncol. 2023 Jul 15;15(7):1119-1134. doi: 10.4251/wjgo.v15.i7.1119. World J Gastrointest Oncol. 2023. PMID: 37546555 Free PMC article. Review.
-
Malignancy and viral infections in Sub-Saharan Africa: A review.Front Virol. 2023;3:1103737. doi: 10.3389/fviro.2023.1103737. Epub 2023 Mar 6. Front Virol. 2023. PMID: 37476029 Free PMC article.
-
Hepatitis B and C in Pregnancy and Children: A Canadian Perspective.Viruses. 2022 Dec 29;15(1):91. doi: 10.3390/v15010091. Viruses. 2022. PMID: 36680130 Free PMC article. Review.
References
-
- Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–1342. - PubMed
-
- Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. 2008;41:4–8. - PubMed
-
- Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect. 2002;4:1219–1225. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources